SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-23-015458
Filing Date
2023-05-04
Accepted
2023-05-04 07:45:26
Documents
56
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q itci-20230331.htm   iXBRL 10-Q 872673
2 EX-10.2 itci-20230331xex102.htm EX-10.2 41677
3 EX-31.1 itci-20230331xex311.htm EX-31.1 9730
4 EX-31.2 itci-20230331xex312.htm EX-31.2 9747
5 EX-32 itci-20230331xex32.htm EX-32 5527
  Complete submission text file 0001628280-23-015458.txt   4407568

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT itci-20230331.xsd EX-101.SCH 27441
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT itci-20230331_cal.xml EX-101.CAL 49218
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT itci-20230331_def.xml EX-101.DEF 133826
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT itci-20230331_lab.xml EX-101.LAB 412569
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT itci-20230331_pre.xml EX-101.PRE 258331
50 EXTRACTED XBRL INSTANCE DOCUMENT itci-20230331_htm.xml XML 657426
Mailing Address 430 EAST 29TH STREET NEW YORK NY 10016
Business Address 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344
Intra-Cellular Therapies, Inc. (Filer) CIK: 0001567514 (see all company filings)

IRS No.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36274 | Film No.: 23886562
SIC: 2834 Pharmaceutical Preparations